ISTH 2020 Congress

I. Martinelli¹, A. Ciavarella¹, M. Abbattista¹, S. Aliberti^2,3, V. De Zan³, C. Folli⁴, M. Panigada⁵, A. Gori^3,6, A. Artoni¹, A.M. Ierardi⁷, G. Carrafiello⁷, V. Monzani⁴, G. Grasselli^3,5, F. Blasi^2,3, F. Peyvandi^1,3

Abstract Number: PB2355

Is Low Molecular Weight Heparin-Calibrated Chromogenic Anti-Xa Assay Suitable for Assessing Anticoagulant Effect of Apixaban in Adolescents?

I. Ćelap¹, S. Margetić¹, R. Mihić¹, J. Obuljen², I. Linarić², J. Leniček Krleža²

Abstract Number: PB2373

Is the Caprini Score a Reliable Tool to Predict the Risk of Venous Thrombosis in Orthopedic Patients?

R. Zambelli^1,2, B. Nemeth³, C. Touw³, F. Rosendaal³, S. Rezende¹, S. Cannegieter³

Abstract Number: PB2368

Lysophosphatidic Acid Promotes Thrombus Stability by Inducing Rapid Formation of Neutrophil Extracellular Traps via a Peptidylarginine Deiminase 4-Dependent Pathway: A New Mechanism of Thrombosis

R. Peng¹, T. Li¹, F. Wang¹, L. Hua¹, S. Liu¹, J. Pei¹, Z. Han¹, S. Pei¹, Z. Zhao², X. Jiang³, X. Chen¹

Abstract Number: PB2385

Point-of-Care Monitoring of Unfractionated Heparin Treatment in the Intensive Care Unit: Preliminary Results of a Comparative Study with Laboratory-based APTT and Anti-Xa Activity

B. Lardinois¹, M. Hardy², S. Lessire², I. Michaux², T. Rotens³, G. Horlait³, M. Bareille¹, H. Jacqmin¹, F. Mullier¹, A.-M. Dive³

Abstract Number: PB2349

ISTH 2020 Congress

Venous Thromboembolism and Cardioembolism » VTE Prophylaxis

A Prospective Observational Multicentre Study to Assess the Incidence of and Risk Factors for (T) Thrombosis (I) in Patients with (L) Lower (L) Limb (I) Injuries (R) Requiring (I) Immobilisation in Ireland (TILLIRI)

An Audit Examining Information Provided to Patients Regarding Venous Thromboembolism (VTE) at Discharge

Antithrombotic Offices of the Arkhangelsk Region Russia

Can an Effective anticoagulation Clinic Reduce Bleeding Risks?

Clinical Indications and Efficacy of Low Molecular Weight Heparin (LMWH) in Pregnancy

Dilemma in Initiating Thromboprophylaxis in Critically Ill Patients

Effectiveness of Implementing a Prophylaxis Protocol for Thromboembolic Events in Patients Admitted to a Tertiary Hospital

Effectiveness of Thromboprophylaxis in the Prevention of Peripherally Inserted Central Catheter (PICC) Associated Venous Thromboembolism in Pediatric Patients: A Case-control Study

Efficacy and Safety of Apixaban for the Primary Prevention of VTE among Patients with Gastrointestinal Cancers: A Post-hoc Analysis of the AVERT Trial

Efficacy and Safety of Pre-Operative Insertion of Inferior Vena Cava Filter in Patients Undergoing Bariatric Surgery: A Systematic Review

Factors Associated with Major Bleeding Risk in Medical and Surgical Patients: Findings from a Multi-Center, Cross-Sectional Study (DissolVE-2)

Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Bariatric Surgery

Increased Doses of Low-molecular-weight Heparin in Hospitalized Patients with Covid-19

Is Low Molecular Weight Heparin-Calibrated Chromogenic Anti-Xa Assay Suitable for Assessing Anticoagulant Effect of Apixaban in Adolescents?

Is the Caprini Score a Reliable Tool to Predict the Risk of Venous Thrombosis in Orthopedic Patients?

Lysophosphatidic Acid Promotes Thrombus Stability by Inducing Rapid Formation of Neutrophil Extracellular Traps via a Peptidylarginine Deiminase 4-Dependent Pathway: A New Mechanism of Thrombosis

Point-of-Care Monitoring of Unfractionated Heparin Treatment in the Intensive Care Unit: Preliminary Results of a Comparative Study with Laboratory-based APTT and Anti-Xa Activity

Post-Discharge Hospital-Associated Venous Thromboembolism

Predictors of Venous Thromboembolic Events (VTE) in Patients with Testicular Cancer

Prevalence and Predictors of Thromboembolic Events in Patients with Gastric Cancer